Indeed, while the levels of Gas6 and its soluble receptors one year after the acute disease bear no significant association with persistent organic symptoms, lower Gas6 and sAxl are associated with patients with a history of hair loss following COVID-19. Here, GAS6 is linked to COVID-19.